Capital International LTD Catalent, Inc. Transaction History

Capital International LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $7.44 Million - $8.65 Million	-62,217 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $607,749 - $792,462	5,567 Added 9.83%	62,217 $8.28 Million
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $176,397 - $203,383	1,758 Added 3.2%	56,650 $6.13 Million
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $722,142 - $891,170	7,114 Added 14.89%	54,892 $5.78 Million
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $4.1 Million - $5.03 Million	47,778 New	47,778 $4.97 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

Stay updated on Capital International LTD with notifications on news.